NEWS
ADVERTISE WITH US
Home  >  News
FDA approves clinical trial on COVID-19 vaccine mix-and-match
ABS-CBN News
Posted at Nov 19 2021 12:46 PM | Updated as of Nov 19 2021 12:57 PM
A health worker show vials of the AstraZeneca COVID-19 vaccine at the Bakuna Bus (Vaccine Bus) by the Philippine Red Cross (PRC) in Manila on November 18, 2021. Jonathan Cellona, ABS-CBN News
MANILA— The Food and Drug Administration has approved the clinical trial on combining different COVID-19 vaccine brands for inoculation, an official said Friday.
The FDA approved the study on Tuesday and started screening applicants the next day at its trial site in Marikina, said Rowena Guevara, Department of Science and Technology Undersecretary for Research and Development.
Some 3,000 participants are needed in the clinical trial, Guevara said.
"Natapos na finally ang ating regulatory review ng mix and match at ang aplikasyon para sa clinical trial ay naaprubahan na ng FDA nung Nov. 16," she said in a virtual press briefing.
(We've finished the regulatory review of mix and match and the application for clinical trial was approved by the FDA on Nov. 16.)
The rollout of booster shots for health care workers, which began Wednesday, will help in collecting data for the trial, Guevara added.
More details to follow. 
FDA approves clinical trial on COVID-19 vaccine mix-and-match
0:00/0:00
Watch more on iWantTFC
Video courtesy of PTV4
Read More:  FDA   Food and Drug Administration   COVID-19 vaccine   mix and match   COVID-19 vaccine mix-and-match clinical trial   clinical trial   Rowena Guevara  
SOCIAL WEB
DOH: We are finalizing the latest Case Bulletin, and will send once available. #COVID19
25 m
BREAKING: The Department of Health reports 492 new cases of the omicron variant.

2 h
© 2022 ABS-CBN Corporation. All Rights Reserved.
ABOUT
CAREERS
PRIVACY
TERMS
CONTACT US
ADVERTISE WITH US




Welcome, Kapamilya!
We use cookies to improve your browsing experience.
Continuing to use this site means you agree to our use of cookies.
Tell me more!